Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c Mice

Pharmacologic Advances in the Treatment and Prevention of Respiratory Syncytial Virus

(2010) Kerry M. Empey et al.   CLINICAL INFECTIOUS DISEASES

Respiratory syncytial virus disease: update on treatment and prevention

(2010) Leonard R Krilov   Expert Review of Anti-Infective Therapy

Therapeutic targeting of respiratory syncytial virus G-protein

(2010) Lawrence M Kauvar et al.   Immunotherapy

Prophylactic Treatment with a G Glycoprotein Monoclonal Antibody Reduces Pulmonary Inflammation in Respiratory Syncytial Virus (RSV)-Challenged Naive and Formalin-Inactivated RSV-Immunized BALB/c Mice

(2010) G. U. Radu et al.   JOURNAL OF VIROLOGY

Respiratory Syncytial Virus Vaccine Development

(2009) Yoshihiko Murata   CLINICS IN LABORATORY MEDICINE

Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab')2 components mediates reduced pulmonary inflammation in mice

(2009) C. Miao et al.   JOURNAL OF GENERAL VIROLOGY

Potent High-Affinity Antibodies for Treatment and Prophylaxis of Respiratory Syncytial Virus Derived from B Cells of Infected Patients

(2009) E. J. Collarini et al.   JOURNAL OF IMMUNOLOGY

Therapeutic Monoclonal Antibody Treatment Targeting Respiratory Syncytial Virus (RSV) G Protein Mediates Viral Clearance and Reduces the Pathogenesis of RSV Infection in BALB/c Mice

(2009) Lia M. Haynes et al.   JOURNAL OF INFECTIOUS DISEASES

The Burden of Respiratory Syncytial Virus Infection in Young Children

(2009) Caroline Breese Hall et al.   NEW ENGLAND JOURNAL OF MEDICINE